Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51

United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026

Add to watchlist

What the insiders did Mostly scheduled

By person

20 insiders · 135 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

George L Sing

Director

—

$20.38M (9) scheduled

−$20.38M

27,297

0.027%

$26.51M

−4.0%

Huda Y Zoghbi

Director

—

$9.14M (14) scheduled

−$9.14M

1,703

0.002%

$1.65M

+23.2%

Christine A Poon

Director

—

$7.59M (6) scheduled

−$7.59M

5,219

0.005%

$5.07M

+140.3%

Joseph J Larosa

EVP General Counsel and Secret

—

$4.31M (2) scheduled

−$4.31M

44,726

0.044%

$43.43M

+16.6%

Andrew J Murphy

Co-Chief Scientific Officer

—

$3.20M (27) scheduled

−$3.20M

51,193

0.050%

$49.71M

−2.9%

Marion McCourt

EVP Commercial

—

$2.99M (3) scheduled

−$2.99M

11,090

0.011%

$10.77M

−15.7%

Jason Pitofsky

SVP Controller

—

$1.87M (12) scheduled

−$1.87M

4,272

0.004%

$4.15M

+1.6%

Bonnie L Bassler

Director

—

$1.77M (2) scheduled

−$1.77M

1,703

0.002%

$1.65M

+23.2%

Michael S Brown

Director

—

$1.69M (1) scheduled

−$1.69M

12,865

0.013%

$12.49M

+2.6%

Kathryn Guarini

Director

—

$1.02M (3) scheduled

−$1.02M

603

<0.001%

$585.55K

+113.8%

Arthur F Ryan

Director

—

$434.68K (48) scheduled

−$434.68K

17,303

0.017%

$16.80M

−1.6%

George Yancopoulos

Bd. Co-Chair, President & CSO

—

—

—

310,460

0.302%

$301.48M

+5.1%

Leonard S Schleifer

Bd. Co-Chair, President & CEO

—

—

—

214,523

0.209%

$208.31M

+8.9%

Neil Stahl

EVP Research and Development

—

—

—

48,829

0.047%

$47.42M

−1.6%

Christopher R. Fenimore

EVP Finance CFO

—

—

—

25,249

0.025%

$24.52M

+34.1%

Plew Daniel P Van

EVP & General Mgr, Industrial

—

—

—

21,673

0.021%

$21.05M

+6.4%

Joseph L Goldstein

Director

—

—

—

6,703

0.007%

$6.51M

+5.0%

N Anthony Coles

Director

—

—

—

1,714

0.002%

$1.66M

+23.0%

Craig B. Thompson

Director

—

—

—

775

<0.001%

$752.57K

+70.7%

David P Schenkein

Director

—

—

—

603

<0.001%

$585.55K

+113.8%